{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:23:59Z","timestamp":1765268639495},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00115-020-00881-5","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T13:02:31Z","timestamp":1583240551000},"page":"207-215","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostik und Fr\u00fcherkennung bipolarer St\u00f6rungen"],"prefix":"10.1007","volume":"91","author":[{"given":"Martin","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"881_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4088\/JCP.v63n0206","volume":"63","author":"DJ Kupfer","year":"2002","unstructured":"Kupfer\u00a0DJ, Frank\u00a0E, Grochocinski\u00a0VJ et\u00a0al (2002) Demographic and clinical characteristics of individuals in a\u00a0bipolar disorder registry. J\u00a0Clin Psychiatry 63:120\u2013125","journal-title":"J Clin Psychiatry"},{"key":"881_CR2","first-page":"2","volume":"23","author":"GS Sachs","year":"2003","unstructured":"Sachs\u00a0GS (2003) Unmet clinical needs in bipolar disorder. J\u00a0Clin Psychopharmacol 23:2\u2013S8","journal-title":"J Clin Psychopharmacol"},{"key":"881_CR3","isbn-type":"print","volume-title":"Internationale Klassifikation psychischer St\u00f6rungen. ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien","year":"2015","unstructured":"Dilling\u00a0H et al (Hrsg) (2015) Internationale Klassifikation psychischer St\u00f6rungen. ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien, 10.\u00a0Aufl. Hogrefe, G\u00f6ttingen. ISBN 978-3-456-85560\u20118","ISBN":"http:\/\/id.crossref.org\/isbn\/9783456855608","edition":"10"},{"key":"881_CR4","volume-title":"Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen DSM-5","author":"American Psychiatric Association","year":"2018","unstructured":"American Psychiatric Association (2018) Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen DSM\u20115, 2.\u00a0Aufl. Hogrefe, G\u00f6ttingen (korrigierte Deutsche Ausgabe)","edition":"2"},{"key":"881_CR5","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.4088\/JCP.0408e12","volume":"69","author":"E Vieta","year":"2008","unstructured":"Vieta\u00a0E (2008) Defining the bipolar spectrum and treating bipolar II disorder. J\u00a0Clin Psychiatry 69:e12","journal-title":"J Clin Psychiatry"},{"key":"881_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-0327(03)00195-2","volume":"84","author":"J Angst","year":"2005","unstructured":"Angst\u00a0J, Sellaro\u00a0R, Stassen\u00a0HH, Gamma\u00a0A (2005) Diagnostic conversion from depression to bipolar disorders: results of a\u00a0long-term prospective study of hospital admissions. J\u00a0Affect Disord 84:149\u2013157","journal-title":"J Affect Disord"},{"key":"881_CR7","unstructured":"DGBS e.\u202fV, DGPPN e.\u202fV (2019) S3-Leitlinie zur Diagnostik und Therapie Bipolarer St\u00f6rungen. Langversion. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/038-019l_S3_Bipolare-Stoerungen-Diagnostik-Therapie_2019-11.pdf"},{"key":"881_CR8","volume-title":"Diagnostik affektiver St\u00f6rungen (Kompendium Psychologische Diagnostik)","author":"M Hautzinger","year":"2002","unstructured":"Hautzinger\u00a0M, Meyer\u00a0TD (2002) Diagnostik affektiver St\u00f6rungen (Kompendium Psychologische Diagnostik) Bd. 3. Hogrefe, G\u00f6ttingen"},{"key":"881_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archgenpsychiatry.2011.87","volume":"68","author":"J Angst","year":"2011","unstructured":"Angst\u00a0J, Azorin\u00a0JM, Bowden\u00a0CL et\u00a0al (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a\u00a0major depressive episode: the BRIDGE study. Arch Gen Psychiatry 68:791\u2013798","journal-title":"Arch Gen Psychiatry"},{"issue":"172","key":"881_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jad.2014.10.024","volume":"1","author":"AF Carvalho","year":"2015","unstructured":"Carvalho\u00a0AF, Takwoingi\u00a0Y, Sales\u00a0PM et al (2015) Screening for bipolar spectrum disorders: a comprehensive meta-analysis of accuracy studies. J\u00a0Affect Disord 1(172):337\u2013346","journal-title":"J Affect Disord"},{"key":"881_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jad.2010.07.003","volume":"128","author":"TD Meyer","year":"2011","unstructured":"Meyer\u00a0TD, Bernhard\u00a0B, Born\u00a0C et al (2011) The hypomania checklist-32 and the mood disorder questionnaire as screening tools\u2014going beyond samples of purely mood-disordered patients. J\u00a0Affect Disord 128:291\u2013298","journal-title":"J Affect Disord"},{"key":"881_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40345-017-0106-4","volume":"5","author":"A Dufy","year":"2017","unstructured":"Dufy\u00a0A, Vandeleur\u00a0C, Hefer\u00a0N, Preisig\u00a0M (2017) The clinical trajectory of emerging bipolar disorder among the highrisk offspring of bipolar parents: current understanding and future considerations. Int J Bipolar Disord 5:37","journal-title":"Int J Bipolar Disord"},{"key":"881_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","volume":"70","author":"C Crump","year":"2013","unstructured":"Crump\u00a0C, Sundquist\u00a0K, Winkleby\u00a0MA, Sundquist\u00a0J (2013) Comorbidities and mortality in bipolar disorder: a\u00a0Swedish national cohort study. JAMA Psychiatry 70:931\u2013939","journal-title":"JAMA Psychiatry"},{"key":"881_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jamapsychiatry.2013.149","volume":"70","author":"A Khan","year":"2013","unstructured":"Khan\u00a0A, Faucett\u00a0J, Morrison\u00a0S, Brown\u00a0WA (2013) Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit\/hyperactivity disorder participating in psychopharmacology clinical trials. JAMA Psychiatry 70:1091\u20131099","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"881_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort\u00a0D, Stubbs\u00a0B, Mitchell\u00a0AJ et al (2015) Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a\u00a0systematic review and meta-analysis. World Psychiatry 14(3):339\u2013347","journal-title":"World Psychiatry"},{"key":"881_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/wps.20309","volume":"15","author":"D Vancampfort","year":"2016","unstructured":"Vancampfort\u00a0D, Correll\u00a0CU, Galling\u00a0B et al (2016) Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a\u00a0systematic review and large scale meta-analysis. World Psychiatry 15:166\u2013174","journal-title":"World Psychiatry"},{"issue":"2","key":"881_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll\u00a0CU, Solmi\u00a0M, Veronese\u00a0M et al (2017) Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a\u00a0large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16(2):163\u2013180","journal-title":"World Psychiatry"},{"key":"881_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/01.psy.0000237316.09601.88","volume":"68","author":"CP Carney","year":"2006","unstructured":"Carney\u00a0CP, Jones\u00a0LE (2006) Medical comorbidity in women and men with bipolar disorders: a\u00a0population-based controlled study 1. Psychosom Med 68:684\u2013691","journal-title":"Psychosom Med"},{"key":"881_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2014.05.002","volume":"166","author":"RS Keefe","year":"2014","unstructured":"Keefe\u00a0RS, Fox\u00a0KH, Davis\u00a0VG et al (2014) The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls. J\u00a0Affect Disord 166:86\u201392","journal-title":"J Affect Disord"},{"key":"881_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.euroneuro.2014.07.017","volume":"25","author":"J Volkert","year":"2015","unstructured":"Volkert\u00a0J, Kopf\u00a0J, Kazmaier\u00a0J et\u00a0al (2015) Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances. Eur Neuropsychopharmacol 25:192\u2013202","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"881_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1399-5618.2007.00487.x","volume":"9","author":"CU Correll","year":"2007","unstructured":"Correll\u00a0CU, Penzner\u00a0JB, Lencz\u00a0T et al (2007) Early identification and high-risk strategies for bipolar disorder. Bipolar Disord 9(4):324\u2013338","journal-title":"Bipolar Disord"},{"issue":"3","key":"881_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/schbul\/sbm028","volume":"33","author":"CU Correll","year":"2007","unstructured":"Correll\u00a0CU, Penzner\u00a0JB, Frederickson\u00a0AM et\u00a0al (2007) Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a\u00a0bipolar mania prodrome. Schizophr Bull 33(3):703\u2013714","journal-title":"Schizophr Bull"},{"issue":"3","key":"881_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jad.2011.06.043","volume":"136","author":"K Leopold","year":"2012","unstructured":"Leopold\u00a0K, Ritter\u00a0P, Correll\u00a0CU et\u00a0al (2012) Risk constellations prior to the development of bipolar disorders: rationale of a\u00a0new risk assessment tool. J\u00a0Affect Disord 136(3):1000\u20131010","journal-title":"J Affect Disord"},{"issue":"7","key":"881_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00115-012-3589-3","volume":"83","author":"A Pfennig","year":"2012","unstructured":"Pfennig\u00a0A, Correll\u00a0CU, Leopold\u00a0K (2012) Early recognition and intervention for bipolar disorders: state of research and perspectives. Nervenarzt 83(7):897\u2013902","journal-title":"Nervenarzt"},{"key":"881_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12831","author":"GL Faedda","year":"2019","unstructured":"Faedda\u00a0GL, Baldessarini\u00a0RJ, Marangoni\u00a0C et\u00a0al (2019) An International Society of Bipolar Disorders task force report: precursors and prodromes of bipolar disorder. Bipolar Disord. https:\/\/doi.org\/10.1111\/bdi.12831","journal-title":"Bipolar Disord"},{"issue":"1","key":"881_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/eip.12082","volume":"8","author":"A Pfennig","year":"2014","unstructured":"Pfennig\u00a0A, Correll\u00a0CU, Marx\u00a0C et\u00a0al (2014) Psychotherapeutic interventions in individuals at risk of developing bipolar disorder: a\u00a0systematic review. Early Interv Psychiatry 8(1):3\u201311","journal-title":"Early Interv Psychiatry"},{"issue":"1","key":"881_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/070674371305800106","volume":"58","author":"M Hauser","year":"2013","unstructured":"Hauser\u00a0M, Correll\u00a0CU (2013) Significance of prodromal symptoms of bipolar disorder in childhood and adolescence. Can J Psychiatry 58(1):22\u201331","journal-title":"Can J Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-020-00881-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-020-00881-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-020-00881-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T01:12:39Z","timestamp":1614733959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-020-00881-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1007\/s00115-020-00881-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"3 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Sch\u00e4fer war beratend t\u00e4tig f\u00fcr Hexal AG und hat Vortragshonorare bzw. Reisekostenunterst\u00fctzung von Gilead, Hexal AG, Servier und Jansen-Cilag angenommen. C.U.\u00a0Correll war beratend t\u00e4tig f\u00fcr bzw. hat Honorare erhalten von: Alkermes, Allergan, Angelini, Boehringer-Ingelheim, Gedeon Richter, Gerson Lehrman Group, Indivior, IntraCellular Therapies, Janssen\/J&J, LB Pharma, Lundbeck, MedAvante-ProPhase, Medscape, Merck, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon, Sunovion, Supernus, Takeda und Teva. Er stellte seine Expertise f\u00fcr Bristol-Myers Squibb, Janssen und Otsuka zur Verf\u00fcgung. Er war im Data Safety Monitoring Board vertreten f\u00fcr Boehringer-Ingelheim, Lundbeck, Rovi, Supernus und Teva. Er hat Honorare von UpToDate und Studienfinanzierungsunterst\u00fctzung von Janssen und Takeda erhalten. Er besitzt Aktien von LB Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}